Paragon 28 Inc Stock Price, News & Analysis

Welcome to our dedicated page for Paragon 28 news (Ticker: FNA), a resource for investors and traders seeking the latest updates and insights on Paragon 28 stock.

Paragon 28, Inc. (NYSE: FNA) is a medical device company based in Englewood, Colorado and exclusively focused on the foot and ankle orthopedic market. This news page aggregates coverage related to the company’s specialized implants, instrumentation and digital tools for foot and ankle surgery, as well as key corporate and regulatory developments.

Readers can find updates on Paragon 28’s participation in major professional meetings such as the American College of Foot and Ankle Surgeons (ACFAS) Annual Scientific Conference and the American Academy of Orthopaedic Surgeons (AAOS) Annual Conference. News from these events often highlights recently launched products, including systems for total ankle replacement, fibula fracture stabilization, syndesmotic repair, minimally invasive bunion correction and single-use power systems for foot and ankle procedures.

Coverage also includes announcements about Paragon 28’s digital initiatives, such as the SMART 28℠ Case Management Portal featuring SMART Bun-Yo-Matic℠, a platform described as integrating AI, data analytics and 3D modeling to streamline surgical planning and execution. Corporate news items may address preliminary revenue updates, conference presentations, board appointments and legal or shareholder-related matters.

In addition, this page features transaction-related news, including the definitive agreement for Zimmer Biomet Holdings, Inc. to acquire Paragon 28 and subsequent regulatory milestones like the expiration of the Hart-Scott-Rodino Act waiting period. By reviewing these articles, investors and observers can follow how Paragon 28’s product launches, strategic initiatives and proposed corporate transactions shape its role in the foot and ankle orthopedic segment over time.